INR 134.0
(-3.6%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 33.85 Million INR | 33.32% |
2022 | 25.39 Million INR | 73.46% |
2021 | 14.64 Million INR | 377.81% |
2020 | 3.06 Million INR | 734.88% |
2019 | 367 Thousand INR | -49.73% |
2018 | 730 Thousand INR | 212.14% |
2017 | -651 Thousand INR | 89.58% |
2016 | -6.24 Million INR | 45.63% |
2015 | -11.48 Million INR | -380.87% |
2014 | 4.09 Million INR | 81.09% |
2013 | 2.25 Million INR | 470.88% |
2012 | 395.62 Thousand INR | -4.4% |
2011 | 413.82 Thousand INR | -88.16% |
2010 | 3.49 Million INR | -31.0% |
2009 | 5.06 Million INR | -96.99% |
2008 | 168.3 Million INR | 4583.03% |
2007 | 3.59 Million INR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 11.94 Million INR | 34.85% |
2023 Q4 | 8.85 Million INR | -12.25% |
2023 Q3 | 10.09 Million INR | 28.07% |
2023 FY | 33.85 Million INR | 33.32% |
2023 Q2 | 7.88 Million INR | 12.17% |
2023 Q1 | 7.02 Million INR | 41.88% |
2022 Q2 | 7.13 Million INR | 8.19% |
2022 FY | 25.39 Million INR | 73.46% |
2022 Q4 | 4.95 Million INR | -26.3% |
2022 Q3 | 6.71 Million INR | -5.79% |
2022 Q1 | 6.59 Million INR | 21.04% |
2021 FY | 14.64 Million INR | 377.81% |
2021 Q4 | 5.44 Million INR | 13.03% |
2021 Q1 | 1.96 Million INR | 219.04% |
2021 Q2 | 2.4 Million INR | 22.3% |
2021 Q3 | 4.81 Million INR | 100.08% |
2020 Q1 | 1.19 Million INR | 252.62% |
2020 FY | 3.06 Million INR | 734.88% |
2020 Q4 | -1.65 Million INR | -183.03% |
2020 Q3 | 1.99 Million INR | 29.94% |
2020 Q2 | 1.53 Million INR | 28.28% |
2019 Q1 | 643 Thousand INR | 163.16% |
2019 Q4 | -783 Thousand INR | -932.98% |
2019 FY | 367 Thousand INR | -49.73% |
2019 Q2 | 413 Thousand INR | -35.77% |
2019 Q3 | 94 Thousand INR | -77.24% |
2018 Q2 | 717 Thousand INR | 16.78% |
2018 Q1 | 614 Thousand INR | 19.22% |
2018 Q4 | -1.01 Million INR | -344.71% |
2018 FY | 730 Thousand INR | 212.14% |
2018 Q3 | 416 Thousand INR | -41.98% |
2017 Q4 | 515 Thousand INR | 201.58% |
2017 Q2 | 4.05 Million INR | 186.03% |
2017 Q1 | -4.71 Million INR | -196.85% |
2017 FY | -651 Thousand INR | 89.58% |
2017 Q3 | -507 Thousand INR | -112.49% |
2016 Q1 | -453 Thousand INR | 87.72% |
2016 FY | -6.24 Million INR | 45.63% |
2016 Q4 | -1.58 Million INR | 38.39% |
2016 Q3 | -2.57 Million INR | -66.93% |
2016 Q2 | -1.54 Million INR | -241.06% |
2015 FY | -11.48 Million INR | -380.87% |
2015 Q4 | -3.68 Million INR | -13.41% |
2015 Q3 | -3.25 Million INR | -10.31% |
2015 Q2 | -2.94 Million INR | -84.37% |
2015 Q1 | -1.59 Million INR | -60.4% |
2014 Q2 | 2.15 Million INR | 12.0% |
2014 FY | 4.09 Million INR | 81.09% |
2014 Q4 | -996.91 Thousand INR | -199.1% |
2014 Q3 | 1 Million INR | -53.34% |
2014 Q1 | 1.92 Million INR | 36.66% |
2013 FY | 2.25 Million INR | 470.88% |
2013 Q1 | -2.25 Million INR | -355.95% |
2013 Q2 | 192 Thousand INR | 108.52% |
2013 Q3 | 409 Thousand INR | 113.02% |
2013 Q4 | 1.4 Million INR | 244.39% |
2012 Q3 | 409 Thousand INR | 122.81% |
2012 Q4 | 880.62 Thousand INR | 115.31% |
2012 FY | 395.62 Thousand INR | -4.4% |
2012 Q1 | 899 Thousand INR | 2341.34% |
2012 Q2 | -1.79 Million INR | -299.44% |
2011 Q2 | -73 Thousand INR | -110.43% |
2011 Q1 | 700 Thousand INR | 0.0% |
2011 FY | 413.82 Thousand INR | -88.16% |
2011 Q4 | 36.82 Thousand INR | 114.73% |
2011 Q3 | -250 Thousand INR | -242.47% |
2010 FY | 3.49 Million INR | -31.0% |
2009 FY | 5.06 Million INR | -96.99% |
2008 Q4 | 8.61 Million INR | 0.0% |
2008 FY | 168.3 Million INR | 4583.03% |
2007 FY | 3.59 Million INR | 0.0% |
2007 Q4 | 1.45 Million INR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Chandra Bhagat Pharma Limited | 15.3 Million INR | -121.244% |
Checkpoint Trends Limited | 302.09 Thousand INR | -11107.587% |
Everest Organics Limited | 1.39 Million INR | -2332.256% |
GUJARAT INJECT (KERALA) LTD. | 827.62 Thousand INR | -3990.843% |
NATURO INDIABULL LIMITED | 9.93 Million INR | -240.922% |
NEXUS SURGICAL AND MEDICARE LI | 2.13 Million INR | -1487.232% |
Rajnish Wellness Limited | 10.33 Million INR | -227.691% |
Vivo Bio Tech Limited | 25.26 Million INR | -34.018% |